22 分钟
Stockhead on MSNHealth Check: CSL’s blood business saves the day amid declining flu jab ratesCSL has reported a 7% net profit rise for the December half, with its blood-derived products offsetting weak flu vaccination ...
Whether downsizing to a lock-and-go freehold home, purchasing in a life rights village, or opting for a sectional title unit, ...
Fourth quarter revenue of $235.7 million, up 11% year-over-year; full year revenue of $900.0 million, up 13% year-over-year.Fourth quarter calculated current billings of $302.2 million, up 11% year-ov ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果